1-deoxynojirimycin has been researched along with melphalan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chen, TY; Chen, YP; Cheng, YL; Hsieh, CY; Huang, WC; Lin, CF; Lin, CM; Lin, YS; Lu, PJ; Tsai, CC; Tsao, CW; Tseng, PC; Wang, CY; Wang, SH | 1 |
| Carty, MP; Herold-Mende, C; Mirallai, SI; Murphy, PV; Negi, A; Warta, R; Ye, XS; Zhou, J | 1 |
2 other study(ies) available for 1-deoxynojirimycin and melphalan
| Article | Year |
|---|---|
Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
Topics: 1-Deoxynojirimycin; Animals; Apoptosis; Cell Line, Tumor; Ceramides; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Genes, abl; Glucosyltransferases; Glycogen Synthase Kinase 3; Humans; Immunoglobulin G; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melphalan; Mice; Mice, SCID; Morpholines; Mutation; Neoplasms, Experimental; Pyrimidines; Transplantation, Heterologous | 2011 |
N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines.
Topics: 1-Deoxynojirimycin; alpha-L-Fucosidase; Bacteria; Bacterial Proteins; Binding Sites; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; Immunoglobulin G; Inhibitory Concentration 50; Melphalan; Molecular Docking Simulation; Structure-Activity Relationship; Sugar Alcohols | 2019 |